George K Ng - Net Worth and Insider Trading

George K Ng Net Worth

The estimated net worth of George K Ng is at least $38,119 dollars as of 2024-04-23. George K Ng is the CEO of Processa Pharmaceuticals Inc and owns about 20,000 shares of Processa Pharmaceuticals Inc (PCSA) stock worth over $32,000. George K Ng is also the See Remarks of Sorrento Therapeutics Inc and owns about 407,935 shares of Sorrento Therapeutics Inc (SRNE) stock worth over $6,119. Details can be seen in George K Ng's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that George K Ng has not made any transactions after 2024-01-30 and currently still holds the listed stock(s).

Transaction Summary of George K Ng

To

George K Ng Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, George K Ng owns 3 companies in total, including Sorrento Therapeutics Inc (SRNE) , Processa Pharmaceuticals Inc (PCSA) , and First Light Acquisition Group Inc (FLAG) .

Click here to see the complete history of George K Ng’s form 4 insider trades.

Insider Ownership Summary of George K Ng

Ticker Comapny Transaction Date Type of Owner
SRNE Sorrento Therapeutics Inc 2018-02-28 See Remarks
PCSA Processa Pharmaceuticals Inc 2024-01-30 Chief Executive Officer
FLAG First Light Acquisition Group Inc 2023-09-12 director

George K Ng Latest Holdings Summary

George K Ng currently owns a total of 2 stocks. Among these stocks, George K Ng owns 20,000 shares of Processa Pharmaceuticals Inc (PCSA) as of January 30, 2024, with a value of $32,000 and a weighting of 83.95%. George K Ng also owns 407,935 shares of Sorrento Therapeutics Inc (SRNE) as of February 28, 2018, with a value of $6,119 and a weighting of 16.05%.

Latest Holdings of George K Ng

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PCSA Processa Pharmaceuticals Inc 2024-01-30 20,000 1.60 32,000
SRNE Sorrento Therapeutics Inc 2018-02-28 407,935 0.02 6,119

Holding Weightings of George K Ng


George K Ng Form 4 Trading Tracker

According to the SEC Form 4 filings, George K Ng has made a total of 1 transactions in Processa Pharmaceuticals Inc (PCSA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Processa Pharmaceuticals Inc is the acquisition of 10,000 shares on January 30, 2024, which cost George K Ng around $27,000.

According to the SEC Form 4 filings, George K Ng has made a total of 0 transactions in Sorrento Therapeutics Inc (SRNE) over the past 5 years. The most-recent trade in Sorrento Therapeutics Inc is the acquisition of 90,000 shares on February 28, 2018, which cost George K Ng around $895,500.

Insider Trading History of George K Ng

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

George K Ng Trading Performance

GuruFocus tracks the stock performance after each of George K Ng's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by George K Ng is -38.35%. GuruFocus also compares George K Ng's trading performance to market benchmark return within the same time period. The performance of stocks bought by George K Ng within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how George K Ng's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of George K Ng

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -28.05 -38.35 -57.77 -65.78 -62.88 -21.24
Relative Return to S&P 500(%) -26.32 -40.63 -56.18 -71.3 -70.83 -33.19

George K Ng Ownership Network

Ownership Network List of George K Ng

No Data

Ownership Network Relation of George K Ng


George K Ng Owned Company Details

What does Sorrento Therapeutics Inc do?

Who are the key executives at Sorrento Therapeutics Inc?

George K Ng is the See Remarks of Sorrento Therapeutics Inc. Other key executives at Sorrento Therapeutics Inc include director & See Remarks Henry Ji , Chief Financial Officer Najjam Asghar , and See Remarks Jerome B Zeldis .

Sorrento Therapeutics Inc (SRNE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sorrento Therapeutics Inc (SRNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sorrento Therapeutics Inc (SRNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sorrento Therapeutics Inc (SRNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sorrento Therapeutics Inc Insider Transactions

No Available Data

George K Ng Mailing Address

Above is the net worth, insider trading, and ownership report for George K Ng. You might contact George K Ng via mailing address: C/o Sorrento Therapeutics, Inc., 6042 Cornerstone Court West, Suite B, San Diego Ca 92121.

Discussions on George K Ng

No discussions yet.